How to transform millennials into monthly donors

The Advisory Board Company | The Advancement Forum | Advancement Blog
Published: July 24, 2017

Millennials. There are many claims about this generation—they’ve done everything from kill the movie-going experience to spend their retirement money on avocado toast. 

Whether these claims are true or not, one thing is clear: it's becoming harder and harder to obtain and count on millennial alumni giving.

How the Cleveland Clinic saved $1M by reducing cancer patient readmissions

The Advisory Board Company | The Oncology Roundtable | Oncology Rounds Blog
Published: June 6, 2016

Unplanned readmissions are costly, adding up to an estimated $12 billion a year for Medicare. Small steps, such as ensuring that patients leave the hospital with clear discharge instructions, can decrease the likelihood of readmissions by 30%. Yet, 91% of chronically ill patients do not receive a written care plan at discharge, and 72% leave the hospital without scheduling a follow-up appointment.

Fire trucks and frogs: 5 ways to reduce the need for imaging sedation in kids

The Advisory Board Company | Imaging Partnership Performance | The Reading Room Blog
Published: June 29, 2016

When it comes to kid-friendly imaging, safety concerns are often top-of-mind. Pediatric imaging providers regularly note the challenges associated with sedating children and seek ways to reduce the need for sedation and its associated risks whenever possible.

We took a deeper look at the way pediatric imaging programs are decreasing the need for sedation—and effective strategies one organization put into practice.

Here’s why patients don’t enroll in your clinical trials

With the announcement of Vice President Biden’s Cancer Moonshot earlier this year, there’s been a resurgence of national interest in cancer research, and for good reason. Clinical trials are responsible for most of the advances we’ve made in cancer treatment so far, and will be critical in helping us continue to improve treatment.

But despite the importance of clinical trials, relatively few cancer patients participate in them. To figure out why, Memorial Sloan Kettering surveyed almost 2,000 consumers and providers—keep reading to find out what they learned. 

Mythbusters: The path to value-based care

The Advisory Board Company | The Health Care Industry Committee | The Bridge Blog
Published: August 18, 2016

For several years you’ve been hearing about the transition to value-based payment. But enough talk. When it comes down to it, are providers really taking on downside financial risk with payers?

To answer this, our colleagues at the Financial Leadership Council surveyed over 100 CFOs—and the short answer is yes and no: yes, there has been movement toward value-based payment, but no, hospitals aren’t putting a lot of dollars at risk through these types of contracts.

A conversation with Ron Scherer, reporter for the Christian Science Monitor

onPoverty.org | On the Beat Blog 
Published: February 4, 2012

Ron Scherer is a reporter for the Christian Science Monitor, where he has worked for 36 years. Previously, he worked for U.S. News & World Report and United Press International, and wrote for The Armored Sentinel at the U.S. Army base in Fort Hood, Texas, where he served during the Vietnam War.

Scherer spoke with onPoverty about his favorite poverty-related stories, how the digital age has affected poverty coverage at The Monitor, and what he hopes the future holds for poverty coverage in the media.

3 places you can’t miss in Bogota

Personal travel blog | WanderWoman
Published: July 10, 2017

I love the feeling of waking up in a new place. How the sounds bleed in bit by bit—people in the street, unfamiliar cars, the clattering of wheels and feet—until they’re accompanied by smells, feelings, a flash of sunlight through a curtain.

In addition to the classics (Monserrate, Plaza Bolívar, Museo de Oro), here are three different recommendations from my time in Bogota.